Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
---|---|---|---|---|---|---|---|
ENST00000448983 | ASIC2-203 | 750 | - | - | - (aa) | - | - |
ENST00000225823 | ASIC2-201 | 3443 | - | ENSP00000225823 | 563 (aa) | - | Q16515 |
ENST00000583395 | ASIC2-205 | 508 | - | - | - (aa) | - | - |
ENST00000579816 | ASIC2-204 | 559 | - | - | - (aa) | - | - |
ENST00000359872 | ASIC2-202 | 3179 | - | ENSP00000352934 | 512 (aa) | - | Q16515 |
ensgID | Trait | pValue | Pubmed ID |
---|---|---|---|
ENSG00000108684 | Body Weight | 2.38648693595419E-8 | 17903300 |
ENSG00000108684 | Body Weight | 2.42777359297714E-8 | 17903300 |
ENSG00000108684 | Body Weight | 2.10203284994182E-8 | 17903300 |
ENSG00000108684 | Body Weight | 2.11323545786742E-8 | 17903300 |
ENSG00000108684 | Gout | 3.69207964046275E-11 | - |
ENSG00000108684 | Stroke | 3.0862344E-004 | 19369658 |
ENSG00000108684 | Stroke | 5.6735390E-004 | 19369658 |
ENSG00000108684 | Blood Pressure | 8.823e-005 | - |
ENSG00000108684 | Fantasy | 8.925e-005 | - |
ENSG00000108684 | Fantasy | 4.508e-005 | - |
ENSG00000108684 | Emotions | 7.442e-005 | - |
ENSG00000108684 | Body Mass Index | 6.1580000E-005 | - |
ENSG00000108684 | Obesity | 3.6830000E-005 | - |
ENSG00000108684 | Obesity | 1.2520000E-005 | - |
ENSG00000108684 | Body Weight | 9.1940000E-005 | - |
ENSG00000108684 | Body Weight | 1.4780000E-005 | - |
ENSG00000108684 | Blood Pressure | 5.1620000E-005 | - |
ENSG00000108684 | C-Reactive Protein | 5.0810000E-005 | - |
ENSG00000108684 | Cholesterol, HDL | 8.5830000E-005 | - |
ENSG00000108684 | Cholesterol, HDL | 6.5130000E-005 | - |
ENSG00000108684 | Leukocyte Count | 9.9640000E-005 | - |
ENSG00000108684 | Body Mass Index | 4.8274079E-006 | - |
ENSG00000108684 | Anatomy | 5.6168726E-005 | - |
ENSG00000108684 | Platelet Function Tests | 2.0100000E-006 | - |
ENSG00000108684 | Platelet Function Tests | 1.0150300E-005 | - |
ENSG00000108684 | Platelet Function Tests | 2.1159977E-007 | - |
ENSG00000108684 | Platelet Function Tests | 8.2978604E-006 | - |
ENSG00000108684 | Platelet Function Tests | 2.6419798E-006 | - |
ENSG00000108684 | Platelet Function Tests | 1.0161654E-006 | - |
ENSG00000108684 | Platelet Function Tests | 1.3086609E-006 | - |
ENSG00000108684 | Platelet Function Tests | 1.3767600E-005 | - |
ENSG00000108684 | Child Development Disorders, Pervasive | 6.3000000E-005 | - |
ENSG00000108684 | Cytokine Receptor gp130 | 4.4610000E-005 | - |
ENSG00000108684 | Homocysteine | 1.3650000E-005 | - |
ENSG00000108684 | Homocysteine | 2.3800000E-005 | - |
ENSG00000108684 | Sex Hormone-Binding Globulin | 1.1490000E-006 | - |
ENSG00000108684 | 3-hydroxy-1-methylpropylmercapturic acid | 1E-6 | 26053186 |
ENSG00000108684 | Smoking | 1E-6 | 26053186 |
ENSG00000108684 | Angiotensin-Converting Enzyme Inhibitors | 7E-7 | 28030426 |
ENSG00000108684 | Bronchodilator Agents | 5E-6 | 26634245 |
ENSG00000108684 | Lung Volume Measurements | 5E-6 | 26634245 |
ENSG00000108684 | Blood Coagulation Factors | 2E-6 | 21810271 |
ENSG00000108684 | Factor VIII | 2E-6 | 21810271 |
ENSG00000108684 | Electrocardiography | 1E-7 | 24324551 |
ENSG00000108684 | Trypanosoma cruzi | 1E-7 | 24324551 |
ENSG00000108684 | Amyotrophic lateral sclerosis 1 | 4E-6 | 24529757 |
ENSG00000108684 | Longevity | 6E-6 | 26912274 |
ENSG00000108684 | Electrocardiography | 9E-6 | 24324551 |
ENSG00000108684 | Trypanosoma cruzi | 9E-6 | 24324551 |
ENSG00000108684 | Coronary Disease | 6E-6 | 21378988 |
ENSG00000108684 | Hypothyroidism | 7E-6 | 22493691 |
ENSG00000108684 | Chemokine CCL2 | 4E-6 | 23251661 |
ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
---|---|---|---|---|---|---|---|---|---|
ENSG00000108684 | rs17782805 | 17 | 33568429 | ? | Angiotensin-converting enzyme inhibitor intolerance | 28030426 | [1.444594-2.33528] | 1.836717 | EFO_0005325 |
ENSG00000108684 | rs144908958 | 17 | 33205396 | A | Post bronchodilator FEV1/FVC ratio | 26634245 | unit increase | 0.616 | GO_0097366|EFO_0004713 |
ENSG00000108684 | rs7213812 | 17 | 33121631 | C | Longevity | 26912274 | [NR] | 1.29 | EFO_0004300 |
ENSG00000108684 | rs320637 | 17 | 33338310 | ? | Amyotrophic lateral sclerosis (sporadic) | 24529757 | EFO_0001357 | ||
ENSG00000108684 | rs72819126 | 17 | 33158862 | ? | 3-hydroxy-1-methylpropylmercapturic acid levels in smokers | 26053186 | [NR] unit decrease | 0.5993 | EFO_0004318|EFO_0007015 |
ENSG00000108684 | rs117364231 | 17 | 33979404 | ? | PR interval in Tripanosoma cruzi seropositivity | 24324551 | EFO_0004462|EFO_0005530 | ||
ENSG00000108684 | rs116908816 | 17 | 34095680 | ? | QT interval in Tripanosoma cruzi seropositivity | 24324551 | EFO_0004682|EFO_0005530 | ||
ENSG00000108684 | rs17808461 | 17 | 33066684 | A | Obesity-related traits | 23251661 | [NR] pg/mL increase | 0.02 | EFO_0004749 |
ENSG00000108684 | rs9910292 | 17 | 33037523 | T | Mosquito bite size | 28199695 | [0.02-0.05] unit decrease | 0.0347797 | EFO_0008378 |
ENSG00000108684 | rs11651843 | 17 | 33454361 | ? | Serum folate levels | 29953918 | EFO_0005111 | ||
ENSG00000108684 | rs9915356 | 17 | 33285476 | A | Self-reported math ability | 30038396 | [0.0093-0.0171] unit increase | 0.0132 | EFO_0004875 |
ENSG00000108684 | rs7213721 | 17 | 33292327 | G | Highest math class taken | 30038396 | [0.008-0.017] unit increase | 0.0125 | EFO_0004875 |
ENSG00000108684 | rs870589 | 17 | 33287436 | A | Educational attainment (MTAG) | 30038396 | [0.0062-0.0112] unit decrease | 0.0087 | EFO_0004784 |
ENSG00000108684 | rs9915356 | 17 | 33285476 | A | Self-reported math ability (MTAG) | 30038396 | [0.01-0.017] unit increase | 0.0135 | EFO_0004875 |
ENSG00000108684 | rs870589 | 17 | 33287436 | A | Highest math class taken (MTAG) | 30038396 | [0.0098-0.0164] unit decrease | 0.0131 | EFO_0004875 |
ENSG00000108684 | rs59692040 | 17 | 33313040 | T | Cognitive performance (MTAG) | 30038396 | [0.0096-0.019] unit increase | 0.0143 | EFO_0008354 |
ENSG00000108684 | rs319748 | 17 | 33227515 | A | Menstruation quality of life impact (bowel movement) | 29855537 | [0.11-0.26] unit decrease | 0.1860469 | EFO_0009366 |
ENSG00000108684 | rs117217798 | 17 | 33156215 | C | Interleukin-16 levels | 27989323 | [0.12-0.29] SD units increase | 0.2036 | EFO_0008173 |
ENSG00000108684 | rs1354492 | 17 | 33410403 | A | vWF and FVIII levels | 21810271 | [0.10-0.22] IU/dL increase | 0.16 | EFO_0004630|EFO_0004634 |
ENSG00000108684 | rs9901756 | 17 | 34137135 | A | Hypothyroidism | 22493691 | [1.11-1.32] | 1.21 | EFO_0004705 |
ENSG00000108684 | rs11650066 | 17 | 33960430 | ? | Coronary heart disease | 21378988 | EFO_0001645 | ||
ENSG00000108684 | rs11652874 | 17 | 33643464 | G | Severe gingival inflammation | 28459102 | [0.48-1] unit increase | 0.740595 | HP_0000225 |
ENSG00000108684 | rs80343429 | 17 | 33229663 | A | Clopidogrel active metabolite levels | 28207573 | [NR] unit increase | 8.01 | EFO_0007966 |
ENSG00000108684 | rs34187563 | 17 | 33399144 | T | Depression (broad) | 29662059 | [0.004-0.0088] unit decrease | 0.0064 | EFO_0003761 |
ENSG00000108684 | rs560769564 | 17 | 33036696 | ? | General cognitive ability | 29844566 | z-score decrease | 4.777 | EFO_0004337 |
ENSG00000108684 | rs140016681 | 17 | 33973273 | ? | Reaction time | 29844566 | [0.0044-0.0111] unit increase | 0.0077347 | EFO_0008393 |
ENSG00000108684 | rs1875872 | 17 | 33468698 | A | Plasma parathyroid hormone levels | 30134803 | [0.081-0.199] unit increase | 0.14 | EFO_0004752 |
ENSG00000108684 | rs4510073 | 17 | 33128407 | ? | Response to long-term oxygen therapy in chronic obstructive pulmonary disease | 30353303 | EFO_0009796|EFO_0000341 | ||
ENSG00000108684 | rs2089164 | 17 | 33384425 | ? | Adolescent idiopathic scoliosis | 30019117 | EFO_0005423 | ||
ENSG00000108684 | rs870589 | 17 | 33287436 | A | Educational attainment (years of education) | 30038396 | [0.0052-0.0106] unit decrease | 0.0079 | EFO_0004784 |
ENSG00000108684 | rs9903658 | 17 | 33729207 | G | Serum bilirubin levels in metabolic syndrome | 30621171 | [0.13-0.3] mg/dL increase | 0.218 | EFO_0004570|EFO_0000195 |
ENSG00000108684 | rs73982435 | 17 | 33146437 | ? | Body mass index | 30595370 | EFO_0004340 | ||
ENSG00000108684 | rs35578035 | 17 | 33422168 | ? | Body mass index | 30595370 | EFO_0004340 | ||
ENSG00000108684 | rs12450465 | 17 | 33053293 | G | Polycystic ovary syndrome | 30343302 | NR unit decrease | 0.8755 | EFO_0000660 |
ENSG00000108684 | rs4365329 | 17 | 33298869 | T | Chronotype | 30696823 | 1.0195894 | EFO_0008328 | |
ENSG00000108684 | rs12938235 | 17 | 33298182 | T | Chronotype | 30696823 | [0.0061-0.0128] unit increase | 0.00944011 | EFO_0008328 |
Go ID | Go_term | PubmedID | Evidence | Category |
---|---|---|---|---|
GO:0003026 | regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback | - | IEA | Process |
GO:0005515 | protein binding | 11802773. | IPI | Function |
GO:0005886 | plasma membrane | - | TAS | Component |
GO:0005887 | integral component of plasma membrane | - | IEA | Component |
GO:0007268 | chemical synaptic transmission | 8626462. | TAS | Process |
GO:0007417 | central nervous system development | 8626462. | TAS | Process |
GO:0007422 | peripheral nervous system development | 8626462. | TAS | Process |
GO:0007602 | phototransduction | - | IEA | Process |
GO:0007605 | sensory perception of sound | - | IEA | Process |
GO:0010447 | response to acidic pH | - | IEA | Process |
GO:0015280 | ligand-gated sodium channel activity | - | IEA | Function |
GO:0015672 | monovalent inorganic cation transport | 8626462. | TAS | Process |
GO:0019229 | regulation of vasoconstriction | - | IEA | Process |
GO:0034220 | ion transmembrane transport | - | TAS | Process |
GO:0034765 | regulation of ion transmembrane transport | - | IEA | Process |
GO:0035418 | protein localization to synapse | - | IEA | Process |
GO:0035725 | sodium ion transmembrane transport | - | IEA | Process |
GO:0042391 | regulation of membrane potential | - | IEA | Process |
GO:0043025 | neuronal cell body | - | IEA | Component |
GO:0043066 | negative regulation of apoptotic process | - | IEA | Process |
GO:0043197 | dendritic spine | - | IEA | Component |
GO:0050915 | sensory perception of sour taste | 19812697. | IMP | Process |
GO:0050974 | detection of mechanical stimulus involved in sensory perception | - | IEA | Process |
GO:0051965 | positive regulation of synapse assembly | - | IEA | Process |
PID | Title | Article | Time | Author | Doi |
---|---|---|---|---|---|
28927426 |
Cancer | Chr | Position | Mutation Type | dbSNP | Protein-change | Allele Freq | RBD |
---|---|---|---|---|---|---|---|
ACC | |||||||
ACC | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
DLBC | |||||||
ESCA | |||||||
ESCA | |||||||
ESCA | |||||||
ESCA | |||||||
ESCA | |||||||
ESCA | |||||||
ESCA | |||||||
ESCA | |||||||
ESCA | |||||||
ESCA | |||||||
GBM | |||||||
GBM | |||||||
GBM | |||||||
GBM | |||||||
GBM | |||||||
GBM | |||||||
HNSC | |||||||
HNSC | |||||||
HNSC | |||||||
HNSC | |||||||
HNSC | |||||||
HNSC | |||||||
HNSC | |||||||
HNSC | |||||||
KIRC | |||||||
KIRC | |||||||
KIRC | |||||||
LGG | |||||||
LGG | |||||||
LIHC | |||||||
LIHC | |||||||
LIHC | |||||||
LIHC | |||||||
LIHC | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
OV | |||||||
OV | |||||||
PAAD | |||||||
PAAD | |||||||
PRAD | |||||||
PRAD | |||||||
PRAD | |||||||
PRAD | |||||||
PRAD | |||||||
PRAD | |||||||
READ | |||||||
READ | |||||||
READ | |||||||
READ | |||||||
READ | |||||||
SARC | |||||||
SARC | |||||||
SARC | |||||||
SARC | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
THYM | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCS | |||||||
UVM |
Cancer | Type | Freq | Q-value |
---|---|---|---|
CESC | |||
DLBC | |||
LGG | |||
PAAD | |||
PAAD | |||
SKCM | |||
THCA | |||
UCS | |||
UVM |
Cancer | P-value | Q-value |
---|---|---|
KIRC | ||
STAD | ||
SKCM | ||
CESC | ||
LAML | ||
GBM | ||
DLBC | ||
LGG | ||
CHOL | ||
OV |